Sopharma AD | Cash Flow
Fiscal year is January-December. All values BGN Thousands.
2013
2014
2015
2016
2017
2018
Net Income before Extraordinaries
29,392.00
20,178.00
-
-
40,153.00
468
Other Funds
3,787.00
210.00
5,685.00
589.00
477.00
468
Funds from Operations
52,449.00
39,384.00
68,198.00
69,453.00
57,245.00
124,252
Net Operating Cash Flow
52,449.00
39,384.00
68,198.00
69,453.00
57,245.00
124,252
Capital Expenditures
36,950.00
26,073.00
22,586.00
18,227.00
23,080.00
Sale of Fixed Assets & Businesses
4,241.00
9,634.00
3,714.00
21,217.00
5,139.00
Purchase/Sale of Investments
1,440.00
8,263.00
9,663.00
2,182.00
2,345.00
Net Investing Cash Flow
27,448.00
31,200.00
35,703.00
9,404.00
80,793.00
Cash Dividends Paid - Total
10,942.00
11,769.00
3,983.00
12,085.00
15,718.00
Issuance/Reduction of Debt, Net
3,403.00
547.00
35,934.00
90,430.00
168,335.00
Net Financing Cash Flow
13,668.00
9,492.00
34,680.00
78,082.00
138,323.00
Net Change in Cash
10,840.00
1,308.00
2,185.00
775.00
285.00
Free Cash Flow
16,489.00
15,647.00
50,406.00
83,670.00
78,037.00
Net Assets from Acquisitions
3,146.00
7.00
18,430.00
6,110.00
55,922.00
Other Sources
23,898.00
13,169.00
27,867.00
21,030.00
100,662.00
Change in Capital Stock
3,110.00
1,520.00
448.00
852.00
13,817.00
Exchange Rate Effect
493.00
-
-
-
-
Other Uses
16,931.00
19,660.00
16,605.00
25,132.00
105,247.00
About Sopharma AD
View Profile
